KCM
VNDA icon

Kingdon Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Kingdon Capital Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-288,392
Closed -$4.04M – 135
2017
Q1 		$4.04M Sell
288,392
-130,340
-31% -$1.86M 0.22% 79
2016
Q4 		$6.68M Buy
418,732
+16,276
+4% +$262K 0.32% 82
2016
Q3 		$6.7M Sell
402,456
-242,112
-38% -$3.26M 0.31% 73
2016
Q2 		$7.21M Buy
644,568
+180,000
+39% +$1.74M 0.4% 64
2016
Q1 		$3.88M Sell
464,568
-470,000
-50% -$3.86M 0.21% 83
2015
Q4 		$8.7M Sell
934,568
-1,008,699
-52% -$10.1M 0.42% 65
2015
Q3 		$21.9M Sell
1,943,267
-198,568
-9% -$2.43M 1.06% 28
2015
Q2 		$27.2M Buy
2,141,835
+209,646
+11% +$2.26M 1.06% 25
2015
Q1 		$18M Sell
1,932,189
-529,116
-21% -$5.98M 0.76% 41
2014
Q4 		$35.2M Buy
2,461,305
+656,125
+36% +$7.76M 1.53% 16
2014
Q3 		$18.7M Buy
1,805,180
+64,780
+4% +$849K 0.84% 29
2014
Q2 		$28.2M Buy
1,740,400
+586,458
+51% +$7.81M 1.08% 17
2014
Q1 		$18.7M Buy
1,153,942
+114,592
+11% +$1.63M 0.96% 31
2013
Q4 		$12.9M Buy
1,039,350
+190,700
+22% +$1.92M 0.59% 53
2013
Q3 		$9.3M Buy
848,650
+402,800
+90% +$4.3M 0.46% 66
2013
Q2 		$3.59M Buy
+445,850
New +$3M 0.21% 122

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kingdon Capital Management's VNDA Position: Q2 2017 in Review

Kingdon Capital Management sold out of Vanda Pharmaceuticals (VNDA) in Q2 2017, closing a stake of 288,392 shares — an estimated $4.04M sold.

Kingdon Capital Management first reported a position in VNDA in Q2 2013 and held it in 16 quarters. The position peaked at $35.2M in Q4 2014. 133 funds tracked by Wall St. Rank hold VNDA as of Q2 2017.

  • Kingdon Capital Management reported no remaining Vanda Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Kingdon Capital Management sold 288,392 Vanda Pharmaceuticals shares in Q2 2017, an estimated $4.04M.
  • Kingdon Capital Management first reported a position in Vanda Pharmaceuticals in Q2 2013 and held it in 16 quarters.
  • Kingdon Capital Management's Vanda Pharmaceuticals position peaked at $35.2M in Q4 2014.
  • 133 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2017.

Based on Kingdon Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.